Literature DB >> 33857464

Low-level exposure to polycyclic aromatic hydrocarbons is associated with reduced lung function among Swedish young adults.

Ayman Alhamdow1, Anna Zettergren1, Inger Kull2, Jenny Hallberg3, Niklas Andersson1, Sandra Ekström4, Marika Berglund1, Craig E Wheelock5, Yona J Essig6, Annette M Krais6, Antonios Georgelis4, Christian H Lindh6, Erik Melén2, Anna Bergström7.   

Abstract

BACKGROUND: Exposure to polycyclic aromatic hydrocarbons (PAHs) has been linked to adverse pulmonary effects. However, the impact of low-level environmental PAH exposure on lung function in early adulthood remains uncertain.
OBJECTIVES: To evaluate the associations between urinary PAH metabolites and lung function parameters in young adults.
METHODS: Urinary metabolites of pyrene, phenanthrene, and fluorene were analysed in 1000 young adults from Sweden (age 22-25 years) using LC-MS/MS. Lung function and eosinophilic airway inflammation were measured by spirometry and exhaled nitric oxide fraction (FeNO), respectively. Linear regression analysis was used to evaluate associations between PAH metabolites and the outcomes.
RESULTS: Median urinary concentrations of 1-OH-pyrene, ∑OH-phenanthrene, and ∑OH-fluorene were 0.066, 0.36, 0.22 μg/L, respectively. We found inverse associations of ∑OH-phenanthrene and ∑OH-fluorene with FEV1 and FVC, as well as between 1-OH-pyrene and FEV1/FVC ratio (adjusted P < 0.05; all participants). An increase of 1% in ∑OH-fluorene was associated with a decrease of 73 mL in FEV1 and 59 mL in FVC. In addition, ∑OH-phenanthrene concentrations were, in a dose-response manner, inversely associated with FEV1 (B from -109 to -48 compared with the lowest quartile of ∑OH-phenanthrene; p trend 0.004) and FVC (B from -159 to -102 compared with lowest quartile; p-trend <0.001). Similar dose-response associations were also observed between ∑OH-fluorene and FEV1 and FVC, as well as between 1-OH-pyrene and FEV1/FVC (p-trend <0.05). There was no association between PAH exposure and FeNO, nor was there an interaction with smoking, sex, or asthma.
CONCLUSION: Low-level PAH exposure was, in a dose-response manner, associated with reduced lung function in young adults. Our findings have public health implications due to i) the widespread occurrence of PAHs in the environment and ii) the clinical relevance of lung function in predicting all-cause and cardiovascular disease mortality.
Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Air pollution; Asthma; Environmental exposure; Polycyclic aromatic hydrocarbons; Urinary metabolites

Year:  2021        PMID: 33857464     DOI: 10.1016/j.envres.2021.111169

Source DB:  PubMed          Journal:  Environ Res        ISSN: 0013-9351            Impact factor:   6.498


  3 in total

Review 1.  The Use of Human Biomonitoring to Assess Occupational Exposure to PAHs in Europe: A Comprehensive Review.

Authors:  Henriqueta Louro; Bruno Costa Gomes; Anne Thoustrup Saber; Anna Laura Iamiceli; Thomas Göen; Kate Jones; Andromachi Katsonouri; Christiana M Neophytou; Ulla Vogel; Célia Ventura; Axel Oberemm; Radu Corneliu Duca; Mariana F Fernandez; Nicolas Olea; Tiina Santonen; Susana Viegas; Maria João Silva
Journal:  Toxics       Date:  2022-08-17

2.  Underground emissions and miners' personal exposure to diesel and renewable diesel exhaust in a Swedish iron ore mine.

Authors:  Louise Gren; Annette M Krais; Eva Assarsson; Karin Broberg; Malin Engfeldt; Christian Lindh; Bo Strandberg; Joakim Pagels; Maria Hedmer
Journal:  Int Arch Occup Environ Health       Date:  2022-03-16       Impact factor: 2.851

3.  Biomarkers after Controlled Inhalation Exposure to Exhaust from Hydrogenated Vegetable Oil (HVO).

Authors:  Annette M Krais; Julie Y Essig; Louise Gren; Carolina Vogs; Eva Assarsson; Katrin Dierschke; Jörn Nielsen; Bo Strandberg; Joakim Pagels; Karin Broberg; Christian H Lindh; Anders Gudmundsson; Aneta Wierzbicka
Journal:  Int J Environ Res Public Health       Date:  2021-06-16       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.